163 related articles for article (PubMed ID: 34778037)
1. Recombinant Human Thrombopoietin Accelerates the Recovery of Platelet in Patients With Lower-Risk Myelodysplastic Syndrome: A Proof-of-Concept Study.
Yang Y; Tang Z; Ji J; Yang C; Chen M; Han B
Front Oncol; 2021; 11():721764. PubMed ID: 34778037
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the efficacy of cyclosporin A combined with recombined human thrombopoietin for treating patients with non-severe aplastic anemia].
Zhang ML; Chen WS; Han B
Zhonghua Xue Ye Xue Za Zhi; 2020 Aug; 41(8):637-642. PubMed ID: 32942816
[No Abstract] [Full Text] [Related]
3. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
[TBL] [Abstract][Full Text] [Related]
4. [Impact on platelet recovery of recombinant human thrombopoietin in severe aplastic anemia patients with allogeneic hematopoietic stem cell transplantation].
Song Y; Zhou F; Song NX; Liu XM; Yu Z; Xie LN; Song XC; Li X
Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):207-211. PubMed ID: 29562465
[No Abstract] [Full Text] [Related]
5. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
[TBL] [Abstract][Full Text] [Related]
6. [Impact of recombinant human thrombopoietin (rhTPO) on short-term response of immunosuppressive therapy in patients with newly diagnosed acquired severe aplastic anemia].
Zhang L; Yang W; Ye L; Zhou K; Jing L; Li Y; Li Y; Li J; Peng G; Song L; Zhao X; Wu Z; Zhang F
Zhonghua Xue Ye Xue Za Zhi; 2015 Mar; 36(3):181-5. PubMed ID: 25854458
[TBL] [Abstract][Full Text] [Related]
7. High- vs regular-dose recombinant human thrombopoietin plus cyclosporine A in patients with newly diagnosed non-severe aplastic anemia: a retrospective cohort study.
Yang Y; Hu Q; Yang C; Chen M; Han B
Hematology; 2024 Dec; 29(1):2298523. PubMed ID: 38156735
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human thrombopoietin promotes platelet recovery in DCAG-treated patients with intermediate-high-risk MDS/hypoproliferative AML.
Chen X; Wang Y; Zang Y; Wei Z; Zhang W; Wei X; Luo G; Chen L; Zhang Y; Xu Z
Medicine (Baltimore); 2023 Mar; 102(13):e33373. PubMed ID: 37000082
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study.
Ding JN; Feng TT; Sun W; Cai XY; Zhang Y; Zhao WF
World J Gastrointest Surg; 2022 Nov; 14(11):1260-1271. PubMed ID: 36504518
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized study.
Mo H; Liu P; Qin Y; He X; Han X; Yao J; Su W; Zhang S; Tang L; Zhao F; Gui L; Yang S; Yang J; Zhou S; Zhang Z; Shi Y
Chronic Dis Transl Med; 2021 Sep; 7(3):190-198. PubMed ID: 34505019
[TBL] [Abstract][Full Text] [Related]
11. A multicentre double-blind, double-dummy, randomised study of recombinant human thrombopoietin versus eltrombopag in the treatment of immune thrombocytopenia in Chinese adult patients.
Mei H; Xu M; Yuan G; Zhu F; Guo J; Huang R; Qin J; Lv T; Qin F; Cai H; Yin P; Qin T; Hu Y
Br J Haematol; 2021 Dec; 195(5):781-789. PubMed ID: 34528239
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of efficacy and safety of two different dose of recombinant human thrombopoietin regimens in severe aplastic anemia patients with immunosuppressive therapy].
Zhou K; Li Y; Li JP; Fan HH; Zhang L; Jing LP; Peng GX; Ye L; Li Y; Song L; Zhao X; Yang WR; Wu ZJ; Chen F; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):205-9. PubMed ID: 27033757
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human thrombopoietin treatment promotes hematopoiesis recovery in patients with severe aplastic anemia receiving immunosuppressive therapy.
Wang H; Dong Q; Fu R; Qu W; Ruan E; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Li L; Shao Z
Biomed Res Int; 2015; 2015():597293. PubMed ID: 25861635
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human thrombopoietin improves platelet counts and reduces platelet transfusion possibility among patients with severe sepsis and thrombocytopenia: a prospective study.
Wu Q; Ren J; Wu X; Wang G; Gu G; Liu S; Wu Y; Hu D; Zhao Y; Li J
J Crit Care; 2014 Jun; 29(3):362-6. PubMed ID: 24405656
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: A clinical study.
Liu Y; Jin G; Sun J; Wang X; Guo L
Int J Infect Dis; 2020 Sep; 98():144-149. PubMed ID: 32561426
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human thrombopoietin is an effective treatment for thrombocytopenia in hemophagocytic lymphohistiocytosis.
Wang Y; Wang Z; Wu L; Zhang J; Wang J; Yan L
Ann Hematol; 2013 Dec; 92(12):1695-9. PubMed ID: 23778995
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human thrombopoietin improved platelet engraftment after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.
Gu J; Liu J; Li X; Zou W; Huang B; Chen M; Li J
Cancer Med; 2021 Nov; 10(21):7641-7649. PubMed ID: 34569193
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of Recombinant Human Thrombopoietin and Recombinant Human Interleukin 11 for Treatment of Chemotherapy Indu-ced Thrombocytopenia in Acute Myeloid Leukaemia Patients].
Tang G; Wang XM; Meng JX; Luan CL; Chen JF; Wu YQ; Zhang XN; He ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):234-238. PubMed ID: 29397850
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Thrombopoietin Effectively Shortens the Time to Response and Increases Platelet Counts in Elderly Patients with Severe Immune Thrombocytopenia.
Li Y; Sun L; Li F; Li Y; Hou Y; Meng Y; Fan X; Cheng Y; Hua F
J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233631
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy.
Somlo G; Sniecinski I; ter Veer A; Longmate J; Knutson G; Vuk-Pavlovic S; Bhatia R; Chow W; Leong L; Morgan R; Margolin K; Raschko J; Shibata S; Tetef M; Yen Y; Forman S; Jones D; Ashby M; Fyfe G; Hellmann S; Doroshow JH
Blood; 1999 May; 93(9):2798-806. PubMed ID: 10216073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
